# Indena S.p.A. · 66-66 · ITALY — FDA import alert red lists: firms subject to detention without physical examination

For Indena S.p.A. · 66-66 · ITALY, import alert is 66-66; import alert name is "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"; country is ITALY; product is Reserpine | Reserpine; product code is 62 C - S 51 Reserpine (Anti-Hypertensive), Active Pharm Ingred/Chems for Further Manuf | 62 O - S 06 Reserpine (Anti-Hypertensive - Part II), Active Pharm Ingred/Chems for Further Manuf; date published is 09/30/2009; address is Via Don Giovanni Minzoni 6 , Settala, Milan ITALY, verified against its source on 2026-09-16.

- **Firm:** Indena S.p.A. _(verified: appears in the quote below)_
- **Import alert:** 66-66
- **Import alert name:** "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"
- **Country:** ITALY _(verified: appears in the quote below)_
- **Address:** Via Don Giovanni Minzoni 6 , Settala, Milan ITALY _(verified: appears in the quote below)_
- **Date published:** 09/30/2009 _(verified: appears in the quote below)_
- **Product code:** 62 C - S 51 Reserpine (Anti-Hypertensive), Active Pharm Ingred/Chems for Further Manuf | 62 O - S 06 Reserpine (Anti-Hypertensive - Part II), Active Pharm Ingred/Chems for Further Manuf _(verified: each item appears in the quote below)_
- **Product:** Reserpine | Reserpine _(verified: each item appears in the quote below)_
- **FDA notes:** 11/2/2000 | 11/2/2000 _(verified: each item appears in the quote below)_

## What the source says

> Indena S.p.A. Date Published : 09/30/2009 Via Don Giovanni Minzoni 6 , Settala, Milan ITALY 62 C - S 51 Reserpine (Anti-Hypertensive), Active Pharm Ingred/Chems for Further Manuf Date Published: 03/29/2019 Desc: Reserpine Notes: 11/2/2000 62 O - S 06 Reserpine (Anti-Hypertensive - Part II), Active Pharm Ingred/Chems for Further Manuf Date Published: 03/29/2019 Desc: Reserpine Notes: 11/2/2000

## Source

- https://www.accessdata.fda.gov/cms_ia/importalert_202.html

Last verified: 2026-09-16. Review by: 2026-11-15.
Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).